-transparent.png){kind=logo}
Cardiac arrhythmias arise from abnormalities of impulse initiation or impulse conduction or both. A review of the electrophysiological mechanisms of the genesis of cardiac arrhythmias and of the electrophysiological principles of the treatment of the cardiac arrhythmias leads to: categorization of antiarrhythmic drugs into five classes based on their dominant cardiac electrophysiological actions; a series of categories of their effects on impulse initiation and impulse conduction in different types of cardiac cells; and a systematic approach to pharmacological management of cardiac arrhythmias.
Related Publications
J T Weng, and
D E Smith, and
P V Moulder
January 1971,
Annual review of pharmacology,
J T Weng, and
D E Smith, and
P V Moulder
January 1985,
Clinical physiology and biochemistry,
J T Weng, and
D E Smith, and
P V Moulder
March 1978,
Angiology,
J T Weng, and
D E Smith, and
P V Moulder
July 1967,
Pharmacology for physicians,
J T Weng, and
D E Smith, and
P V Moulder
January 1975,
Annual review of pharmacology,
J T Weng, and
D E Smith, and
P V Moulder
January 1984,
Annals of the New York Academy of Sciences,
J T Weng, and
D E Smith, and
P V Moulder
January 1969,
Proceedings of the Royal Society of Medicine,
J T Weng, and
D E Smith, and
P V Moulder
September 1980,
Klinische Wochenschrift,
J T Weng, and
D E Smith, and
P V Moulder
January 1981,
Methods and findings in experimental and clinical pharmacology,
J T Weng, and
D E Smith, and
P V Moulder
August 1991,
Cardiovascular drugs and therapy,
